SpinalCyte, LLC Reports the Addition of Nicholas Theodore, M.D. to Clinical Advisory Board
10/22/2012 9:44:05 AM
HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced the addition of Nicholas Theodore, M.D. to its Clinical Advisory Board. Dr. Theodore, Director of Neurosurgery Spine Program, Barrow Neurological Institute, is one of the top spine surgeons and researchers in the country.